Trial Profile
Phase II Study of Proteasome Inhibitor PS-341 For Patients With Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2012
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications B-cell lymphoma; Mantle-cell lymphoma
- Focus Therapeutic Use
- 09 Aug 2012 New trial record